Viewing Study NCT07325461


Ignite Creation Date: 2026-03-26 @ 3:14 PM
Ignite Modification Date: 2026-03-31 @ 2:15 AM
Study NCT ID: NCT07325461
Status: RECRUITING
Last Update Posted: 2026-03-05
First Post: 2026-01-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes
Sponsor: Tandem Diabetes Care, Inc.
Organization:

Study Overview

Official Title: Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes
Status: RECRUITING
Status Verified Date: 2026-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This feasibility study is a prospective, single center, multi-arm study evaluating possible enhancements to the SteadiSet extended wear infusion set.
Detailed Description: All participants will use the SteadiSet insulin infusion set for 6 wear periods of up to 7 days each.

The 2 treatment arms are:

Existing t:slim X2 Users:

* t:slim X2 insulin pump with SteadiSet (43 inches) and an enhanced filling process (3 wear periods)
* t:slim X2 insulin pump with SteadiSet (43 inches) with no side ports (3 wear periods)

Existing Mobi Users:

* Mobi Insulin Pump with SteadiSet (5 inches) and an enhanced filling process (3 wear periods)
* Mobi Insulin Pump and SteadiSet (5 inches) (3 wear periods)

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: